Variation in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene that every GLP-1 compound targets), MC4R (a melanocortin receptor tied to satiety and energy balance), and TCF7L2 (a transcription factor linked to glucose handling and GLP-1 secretion) describes the metabolic terrain a compound acts on
Improved Blood Pressure and Cholesterol Levels In addition to their effects on blood glucose and weight, GLP-1 receptor agonists also contribute to improvements in blood pressure and lipid profiles, which can further reduce the risk of cardiovascular disease. Standard GLP-1 Dosing: What's Established Typical Doses The prescribed doses of GLP-1 receptor agonists are based on extensive clinical research and established therapeutic guidelines
The current rating sits around 3.4 stars, which translates to roughly half the reviews being positive and half being mixed-to-negative
A new weight loss drug currently in the pipeline is retatrutide
Availability depends on provider evaluation, state participation, pharmacy requirements, and clinical eligibility